Learn more

BIOCORTECH

Overview
  • Total Patents
    27
About

BIOCORTECH has a total of 27 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Canada, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CAMBRIDGE ENTPR, BERG BIOSYSTEMS LLC and STIFTELSEN UNIVERSITETSFORSKNI.

Patent filings per year

Chart showing BIOCORTECHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Weissmann Dinah 19
#2 Pujol Jean-Francois 17
#3 Cavarec Laurent 7
#4 Vincent Laurent 7
#5 Deyon Laurence 5
#6 Ciapetti Paola 5
#7 Wermuth Camille-Georges 5
#8 Berthomme Herve 3
#9 Madjar Jean-Jacques 3
#10 Mann John 3

Latest patents

Publication Filing date Title
WO2011161253A1 Editing profiling of pde8a pre -mrna : use as specific biomarker of adars activities in human tissues to diagnose and to predict and assess therapeutic efficacy and/or efficiency or potential drug side effects
EP2202321A1 Evaluation of the potential risk of drug induced mood disturbance and suicide:use of a dedicated platform
CN101743322A Peripherical tissue sample containing cells expressing the 5htr2c and/or adars as markers of the alteration of the mechanism of the 5htr2c mrna editing and its applications
CN1953977A Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol, and applications thereof
FR2865650A1 Use of 14,15 dihydro 20,21-dinoreburnamenin14-ol for the treatment and / or prevention of major lowers and sleep-relief cycle disorders
FR2865649A1 Use of 14,15-dihydro-20,21-dinor-14-eburnameninol to prepare a pharmaceutical composition for treating or preventing major depression
FR2842827A1 NOVEL METHOD OF NUCLEIC ACID ANALYSIS AND ITS USE FOR EVALUATING THE DEGREE OF EDITING OF THE 5-HT2c RECEPTOR mRNA